Therapeutic Asset Ratings
212 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Mnpr-101-Pcta-177Lu
Gastric Cancer
Monopar Therapeutics
P1
C
(37)
Moma-341
Gastric Cancer
MOMA Therapeutics
P1
C
(37)
mrg007
Gastric Cancer
ArriVent BioPharma, Inc.
P1
C
(37)
ngm438
Gastric Cancer
NGM Biopharmaceuticals, Inc
P1
C
(37)
ngm831
Gastric Cancer
NGM Biopharmaceuticals, Inc
P1
C
(37)
nkt3447
Gastric Cancer
NiKang Therapeutics, Inc.
P1
C
(37)
nkt3964
Gastric Cancer
NiKang Therapeutics, Inc.
P1
C
(37)
pb101
Gastric Cancer
Panolos Bioscience
P1
C
(37)
pf-07265028
Gastric Cancer
Pfizer
P1
C
(37)
pf-08046054
Gastric Cancer
Seagen, a wholly owned subsidiary of Pfizer
P1
C
(37)
PIMITESPIB
Gastric Cancer
Taiho Pharmaceutical Co., Ltd.
P1
C
(37)
P-Muc1C-Allo1 Car-T Cells
Gastric Cancer
Poseida Therapeutics, Inc.
P1
C
(37)
Pradusinstobart
Gastric Cancer
M.D. Anderson Cancer Center
P1
C
(37)
Ribociclib
Gastric Cancer
Blueprint Medicines Corporation
P1
C
(37)
Rimiducid
Gastric Cancer
Poseida Therapeutics, Inc.
P1
C
(37)
Rndo-564
Gastric Cancer
Rondo Therapeutics
P1
C
(37)
SAR443216
Gastric Cancer
Sanofi
P1
C
(37)
Son-Dp
Gastric Cancer
Qurgen Inc.
P1
C
(37)
Stro-004
Gastric Cancer
Sutro Biopharma, Inc.
P1
C
(37)
Tas-102
Gastric Cancer
Taiho Pharmaceutical Co., Ltd.
P1
C
(37)
Tas-115
Gastric Cancer
Taiho Pharmaceutical Co., Ltd.
P1
C
(37)
tj033721
Gastric Cancer
I-Mab Biopharma US Limited
P1
C
(37)
Torl-2-307-Adc
Gastric Cancer
TORL Biotherapeutics, LLC
P1
C
(37)
Torl-2-307-Mab
Gastric Cancer
TORL Biotherapeutics, LLC
P1
C
(37)
Trk-950
Gastric Cancer
Toray Industries, Inc
P1
C
(37)
Showing 176 to 200 of 212 assets
Previous
Page 8 of 9
Next